WE ARE INTO SHARING
Regulatory Intelligence
Stay Up To Date
Latest regulatory changes
CBG starts authorizing temporarily different packaging
The Netherlands Marketing authorization holders who want to temporarily supply a medicine in a different packaging in the event of a medicine shortage will need permission from the CBG from 1 January 2023. The CBG will take over this task from the Healthcare and Youth...
Update Guidance document describing the food categories in the Regulation on Food Additives
Europe The European Commission had published an update of the Guidance document describing the food categories in Part E of Annex II to Regulation (EC) No 1333/2008 on Food Additives. In this new version the following changes are made: - update of Category 17, in line...
Mdeon, the Belgian ethical health platform, announces several novelties effective from January 1st, 2023.
Belgium Most important is the increase of hospitality that can be provided to healthcare professionals. The maximum amount for a lunch will be increased to 45€, for a dinner to 90€. A total maximum of 135€/day may be offered as hospitality to HCPs in the context of at...
Update on the pharmacovigilance system for Luxembourg
Luxembourg There has been an update on: New instructions for the preparation and submission of additional risk minimisation material (aRMM) for evaluation and approval in Luxembourg: update contact detail adverse event reportingupdate address to send the printed...
EMA recommends withdrawal of pholcodine medicines from EU market
Europe EMA’s safety committee, PRAC, has concluded its review of medicines containing pholcodine, which are used in adults and children to treat non-productive (dry) cough and, in combination with other active substances, for the treatment of symptoms of...
Drug shortages
The Netherlands Drug shortages are an important issue since the COVID-19 pandemic. According to the Medicines Act, each Marketing Authorisation Holder (MAH) and Wholesaler must ensure that sufficient supply of each medicine is available. The interpretation of...
The FAMHP added a Q&A to their FAQ of Unmet Medical Need
Belgium Please note that the FAMHP added a Q&A to their FAQ of Unmet Medical Need. It concerns the provision of medicinal products for free (or at a reduced cost) to patients when a Medical Need Program is not in place or has ended. Is it possible to give a...
Update Commission Regulation regarding green tea extracts
Europe The Commission Regulation (EU) 2022/2340 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards green tea extracts containing (-)-epigallocatechin-3-gallate has been published on 30 November 2022. This...
New questions and answers from the EMA regarding Titanium Dioxide in Medicines
Europe A new questions and answers concerning titanium dioxide was published by the EMA. The Q&A, including five questions, gives guidance about the replacement or removal of titanium dioxide in medicines. Titanium dioxide (E 171) is commonly used in the...
Register your Industry Single Point of Contact (i-SPOC) on supply and availability
Europe All Marketing authorisation holders (MAHs) should register their Industry Single Point of Contact (i-SPOC) who will inform EMA about the supply and availability of critical medicines identified in the context of a ‘public health emergency’ or a ‘major event’...
Want To Join
Our Current Open Vacancies
Junior Consultant vacancy
Are you keen to discover the pharmaceutical industry and to get introduced to Quality Assurance, Pharmacovigilance, Regulatory Affairs and/or Promotion & Publicity for pharma and healthcare products? As Junior Consultant at IN2Pharma, you will be trained in several of these domains and depending on your skills and interest, we will find out together where your passion lies. Do you hold a Master degree in pharmaceutical or other sciences and are you eager to learn? Apply by sending your CV and motivation to jobs@in2Pharma.com
Medical Affair Vacancy
and for some projects, you also work on site at the clients’ offices for (max.) 1 or 2 days per week.
QA Consultant
Stay Up To Date
In2Pharma News
Phone
+32 16 891 600
Location
Hof Ter Loonst
Terloonststraat 22
1910 Kampenhout
Belgium
info@in2pharma.com